Open AccessImplantable cardioverter defibrillator specific rehabilitation improves health cost outcomes: Findings from the COPE-ICD randomized controlled trial
Author(s) -
Selina Kikkenborg Berg,
Ann-Dorthe Zwisler,
Mette Bjerrum Koch,
Jesper Hastrup Svendsen,
Anne Vinggaard Christensen,
Preben Ulrich Pedersen,
Lau Caspar Thygesen
Publication year - 2015
Publication title -
journal of rehabilitation medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.893
H-Index - 96
eISSN - 1651-2081
pISSN - 1650-1977
DOI - 10.2340/16501977-1920
Subject(s) - medicine , rehabilitation , implantable cardioverter defibrillator , randomized controlled trial , physical therapy , health care , emergency medicine , economics , economic growth
The Copenhagen Outpatient ProgrammE - implantable cardioverter defibrillator (COPE-ICD) trial included patients with implantable cardioverter defibrillators in a randomized controlled trial of rehabilitation. After 6-12 months significant differences were found in favour of the rehabilitation group for exercise capacity, general and mental health. The aim of this paper is to explore the long-term health effects and cost implications associated with the rehabilitation programme; more specifically, (i) to compare implantable cardioverter defibrillator therapy history and mortality between rehabilitation and usual care groups; (ii) to examine the difference between rehabilitation and usual care groups in terms of time to first admission; and (iii) to determine attributable direct costs.